Biostax Corp (BTAX)

[LW89]

What's missing - IMO - is who (or rather what) organization/entity is going to pay for the drug for patients. It could sit in a dbn center forever - booked by IMUN as a legitimate sale under GAAP - but for all practical purposes be channel stuffing....and it would be difficult to track simply because we won't have insight on inventory levels at the distributor. There is so much complexity in all of these dealings for IMUN - I think it is really difficult to say which transactions are at arm's length and which aren't.

What one would hope to see is not that "we have a distribution contract" but rather "the XYZ foundation or the government has allocated $XX dollars towards the purchase of Lodonal" - that would be a sale.

I hope I'm proven wrong.